Feedback (FDBK) Competitors GBX 19.50 0.00 (0.00%) (As of 12/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades FDBK vs. INHC, IQAI, DVRG, TRLS, SENS, EMIS, CRW, INS, KOO, and COGShould you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry. Feedback vs. Induction Healthcare Group IQ-AI DeepVerge Trellus Health Sensyne Health EMIS Group Craneware Instem Kooth Cambridge Cognition Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations. Which has more volatility & risk, FDBK or INHC? Feedback has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the S&P 500. Does the MarketBeat Community favor FDBK or INHC? Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote. CompanyUnderperformOutperformFeedbackOutperform Votes16567.07% Underperform Votes8132.93% Induction Healthcare GroupOutperform Votes1493.33% Underperform Votes16.67% Does the media refer more to FDBK or INHC? In the previous week, Feedback had 2 more articles in the media than Induction Healthcare Group. MarketBeat recorded 3 mentions for Feedback and 1 mentions for Induction Healthcare Group. Induction Healthcare Group's average media sentiment score of 1.62 beat Feedback's score of -0.10 indicating that Induction Healthcare Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Feedback 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Induction Healthcare Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals & insiders have more ownership in FDBK or INHC? 53.2% of Feedback shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 10.8% of Feedback shares are held by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation & earnings, FDBK or INHC? Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFeedback£1.18M2.20-£3.30M-£0.25-78.00Induction Healthcare Group£13.65M0.62-£3.25M-£0.03-300.00 Is FDBK or INHC more profitable? Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -279.16%. Induction Healthcare Group's return on equity of -14.53% beat Feedback's return on equity.Company Net Margins Return on Equity Return on Assets Feedback-279.16% -35.63% -22.99% Induction Healthcare Group -23.86%-14.53%-7.32% SummaryInduction Healthcare Group beats Feedback on 9 of the 15 factors compared between the two stocks. Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Get Feedback News Delivered to You Automatically Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FDBK vs. The Competition Export to ExcelMetricFeedbackHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£2.60M£235.14M£5.21B£1.38BDividend Yield4.56%6.58%5.38%11.77%P/E Ratio-78.00780.81119.271,511.49Price / Sales2.20296.281,305.34381,194.92Price / Cash1.1238.9042.3134.14Price / Book0.344.774.892.95Net Income-£3.30M-£5.84M£119.35M£128.31M7 Day Performance-1.27%2.88%3.24%0.64%1 Month Performance-20.41%6.80%3.31%-0.03%1 Year Performance-72.92%8.15%32.85%105.51% Feedback Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FDBKFeedbackN/AGBX 19.50flatN/A-72.9%£2.60M£1.18M-78.0024Insider TradeNews CoverageINHCInduction Healthcare GroupN/AGBX 9.65+7.2%N/A-63.2%£9.06M£13.65M-321.6774Positive NewsGap UpHigh Trading VolumeIQAIIQ-AIN/AGBX 1.42-3.7%N/A-60.8%£3.16M£538,190.00-13.676DVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.60-1.0%N/A-84.0%£969,000.00£35,000.00-20.0031SENSSensyne HealthN/AGBX 0.35-33.3%N/A+0.0%£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AGBX 1,920flatN/AN/A£1.23B£176.86M4,085.111,560CRWCranewareN/AGBX 2,345-1.5%GBX 2,700+15.1%+42.4%£828.72M£189.27M9,269.23734INSInstemN/AGBX 830flatN/AN/A£199.62M£61.63M5,928.57500KOOKoothN/AGBX 177.80-0.1%GBX 585+229.0%N/A£64.86M£54.17M1,481.67478COGCambridge CognitionN/AGBX 27.89+2.1%N/A-49.9%£11.70M£13.08M-687.5080 Related Companies and Tools Related Companies INHC Alternatives IQAI Alternatives DVRG Alternatives TRLS Alternatives SENS Alternatives EMIS Alternatives CRW Alternatives INS Alternatives KOO Alternatives COG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FDBK) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWhat will be the biggest trades of 2025?From Government Secrets to Triple-Digit Wins The 3 Profit Structures You Need to Know - REGISTER HERE.10 Minute Trades | SponsoredThe 2024 TECH RESETAre we on the edge of the biggest ‘TECH RESET’ in decades?InvestorPlace | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Feedback plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Feedback With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.